Literature DB >> 33420486

Prostate cancer hijacks the microenvironment.

Phillip Thienger1, Mark A Rubin2,3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33420486     DOI： 10.1038/s41556-020-00616-3

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  1 in total

1.  Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.

Authors:  Gustavo Ayala; Jennifer A Tuxhorn; Thomas M Wheeler; Anna Frolov; Peter T Scardino; Makoto Ohori; Marcus Wheeler; Jeffrey Spitler; David R Rowley
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531
  1 in total
  6 in total

Review 1.  Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer.

Authors:  Eshwari Dathathri; Khrystany T Isebia; Fikri Abali; Martijn P Lolkema; John W M Martens; Leon W M M Terstappen; Ruchi Bansal
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

Review 2.  Immunotherapy for prostate cancer: Requirements for a successful regime transfer.

Authors:  Seung-Hwan Jeong; Cheol Kwak
Journal:  Investig Clin Urol       Date:  2022-01

3.  Indolethylamine-N-Methyltransferase Inhibits Proliferation and Promotes Apoptosis of Human Prostate Cancer Cells: A Mechanistic Exploration.

Authors:  Wang Jianfeng; Wang Yutao; Bi Jianbin
Journal:  Front Cell Dev Biol       Date:  2022-02-17

4.  Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting Prostate Cancer Survival.

Authors:  Nan Li; Kai Yu; Zhong Lin; Dingyuan Zeng
Journal:  J Oncol       Date:  2022-02-16       Impact factor: 4.375

Review 5.  Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?

Authors:  Gunhild von Amsberg; Winfried Alsdorf; Panagiotis Karagiannis; Anja Coym; Moritz Kaune; Stefan Werner; Markus Graefen; Carsten Bokemeyer; Lina Merkens; Sergey A Dyshlovoy
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

6.  Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss.

Authors:  Javier Octavio Mejía-Hernández; Simon P Keam; Reem Saleh; Fenella Muntz; Stephen B Fox; David Byrne; Arielle Kogan; Lokman Pang; Jennifer Huynh; Cassandra Litchfield; Franco Caramia; Guillermina Lozano; Hua He; James M You; Shahneen Sandhu; Scott G Williams; Ygal Haupt; Sue Haupt
Journal:  Cell Death Dis       Date:  2022-09-08       Impact factor: 9.685
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.